Your session is about to expire
← Back to Search
Escitalopram + Celecoxib for Inflammation (S&I Trial)
S&I Trial Summary
This trial is investigating the relationship between inflammation in the brain and depression in adults aged 65 and older.
- Inflammation
- Depression
S&I Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowS&I Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 4 trial • 119 Patients • NCT02389465S&I Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the age-qualifying criterion for this trial above or below 25 years of age?
"Patients desiring to join this medical trial must be between 50 and 80 years old."
Are there any opportunities for individuals to participate in this clinical investigation?
"This research project is no longer recruiting participants. It was initially released on August 1st, 2014 and last updated January 27th, 2022. If you are searching for an alternative trial to join, 1627 studies related to depression are currently enrolling patients while 62 trials concerning the combination of Escitalopram + Celecoxib remain available."
Are there any requirements for those wishing to enroll in this research study?
"This clinical trial seeks out 150 patients between the ages of 50 and 80 that are suffering from depression."
What is the current status of Escitalopram in combination with Celecoxib regarding governmental approval?
"The safety of Escitalopram + Celecoxib was rated a 3 due to its status as an approved therapy for medical use - this is classified as Phase 4."
What is the upper limit of participants for this trial?
"Unfortunately, this trial is not currently accepting new candidates. The last update was on January 27th 2022 and the listing first appeared in August of 2014. Nevertheless, there are 1627 other trials recruiting participants with depression, as well as 62 studies looking for enrollees to research Escitalopram alongside Celecoxib."
To what purpose is Escitalopram + Celecoxib typically employed?
"Osteoarthritis (OA) is typically managed through the dual prescription of Escitalopram and Celecoxib. This medication combination has also been effective at mitigating anxiety disorders, obsessive-compulsive disorder, as well as acute pain."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger